Century Therapeutics IPSC
NASDAQ IPSC
$1.65 -0.02 (-1.20%)
At close: Sep 29, 2026 · 4:00 PM EDT

Century Therapeutics (IPSC) Revenue (2022 - 2025)

Updated

Century Therapeutics' Revenue came in at $109.16 million for FY2025, compared with $6.59 million in FY2024.

Analysis

Century Therapeutics (IPSC) Revenue (2022 - 2025) Analysis & Trends

Going back to FY2022, Century Therapeutics' Revenue data covers 4 years.

  • Revenue carries a three-year compound annual growth rate of 175.9% (FY2022 to FY2025).
  • Per Business Quant, earlier years put Revenue at $6.59 million in FY2024 (+194.8%), $2.24 million in FY2023 (-57.0%) and $5.2 million in FY2022.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Revenue (Qtr)
1 Johnson & Johnson 655.56 Bn 574.09 Bn 17.26 Bn 25.31 Bn
2 AbbVie 470.94 Bn 444.10 Bn 12.70 Bn 16.99 Bn
3 Merck 367.14 Bn 321.57 Bn 12.21 Bn 16.61 Bn
4 Novartis Ag 280.33 Bn 236.20 Bn 11.24 Bn 14.41 Bn
5 Astrazeneca 257.78 Bn 231.34 Bn 12.86 Bn 15.38 Bn
6 Amgen 226.04 Bn 181.44 Bn 7.24 Bn 10.05 Bn
7 Gilead Sciences 188.89 Bn 163.01 Bn 6.22 Bn 7.80 Bn
8 Pfizer 163.75 Bn 110.70 Bn 10.94 Bn 15.03 Bn
9 Vertex Pharmaceuticals 133.68 Bn 105.69 Bn 2.84 Bn 3.33 Bn
10 Century Therapeutics 301.51 Mn -202.86 Mn - -
Historic Data

Historic Data

Download Data
DateValue
Mar 31, 2025 109.16 Mn
Dec 31, 2024 4.17 Mn
Sep 30, 2024 791,000.00
Jun 30, 2024 771,000.00
Mar 31, 2024 855,000.00
Dec 31, 2023 268,000.00
Sep 30, 2023 148,000.00
Jun 30, 2023 99,000.00
Mar 31, 2023 1.72 Mn
Dec 31, 2022 521,000.00
Sep 30, 2022 2.22 Mn
Jun 30, 2022 1.40 Mn
Mar 31, 2022 1.06 Mn
API Access

Century Therapeutics Revenue API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=revenue&ticker=IPSC&period=max&api_key=YOUR_API_KEY